Skip to main content

Digital Therapeutics Market to Grow at CAGR of 20.0% through 2028


 The global digital therapeutics market was valued at $3,003.40million in 2020 and is projected to reach $12,695.60million by 2028, registering a CAGR of 20.0%.

COVID-19 Impact on the Digital Therapeutics Market

During the prevalence of COVID-19 pandemic, the digital therapeutics market observed a positive growth. Due to high rate of corona virus transmission, and fear of infection, many heart patients avoided their regular doctor visits and health checkup. Also, due to growing number of infection cases, many private clinics and emergency wards were occupied by corona patients which further restricted normal patients with other disease to see any healthcare professional. Due to these factors, the patients have opted for digital form of therapeutics which has eased their life in pandemic. These factors are likely to drive the digital therapeutics market share growth in the pandemic time period.

Checkout How COVID-19 impacts the Dermacosmetics Market. Click Here to Schedule a Call to Speak our Expert Analyst for Triangulate with your own data @ https://www.researchdive.com/connect-to-analyst/691

Digital Therapeutics Market Analysis

Increasing prevalence of chronic diseases like obesity and diabetes, among people across the world is expected to drive the digital therapeutics growth in the forecast time period. As people across the globe are suffering from various diseases and rate of hospital visits have increased tremendously, they have now focused more on using digital healthcare tools for their regular health follow up. Also, digital therapeutics require less healthcare cost compared to traditional healthcare visits. These factors are further anticipated to boost the market growth in the future.

However, lack of awareness about the availability and usability of digital healthcare applications among people, especially in developing countries is likely to restrain the digital therapeutics market growth in the coming years. Also, lack of reimbursement facilities for digital therapeutics in developing countries like India is further anticipated to impede digital therapeutics market in the next few years.

Due to growing demand for advanced, more reliable, and evidence based treatment options for chronic diseases like obesity, many companies in the market have got opportunities to launch new applications devices for digital therapeutics in the market. For instance, according to a news published on Business Wire, on December 07, 2021, Limbix, a digital therapeutic company, raised $15million in Series A2 financing from investors, to develop treatment options for adolescent mental health disorders. Such factors are likely to boost the digital therapeutics market size growth in future.

Digital Therapeutics Market Segmentation

The digital therapeutics market is segmented based on application, product, and region.

Product

The global digital therapeutics market by product is segmented into software and devices digital therapeutics market. Software digital therapeutics sub-segment is anticipated to have the fastest market growth and generate a revenue of $8,385.10 million in 2028. The sub-segment growth is attributed to the increasing cases of obesity and overweight cases among people, worldwide, due to lack of physical exercise. As the cases of obesity have increased, the demand for software which can properly guide and help patients to reduce their weight has increased. This factor is likely to flourish the market growth in the next few years.

Application

The global digital therapeutics market by application is segmented into diabetes, obesity, cardiovascular disease, central nervous system, respiratory disease, smoking cessation, gastrointestinal disease, and others. The obesity sub-segment is predicted to have the fastest growing revenue in the global market and register a revenue of $2,404.00 million during the forecast period. The growth is attributed to increase in the number of obesity cases among the people across the world due to unhealthy food eating habits. Many companies have now focused on developing software for obese people to manage and reduce their weight. These factors are likely to flourish the market growth in the next few years.

Region:

The Asia-Pacific digital therapeutics market is expected to observe fastest growth and register a revenue of $2,069.40 million in the predicted time span. The regional growth is attributed to presence of well-established healthcare companies in the market and their constant effort to develop and launch new products. Also, growing prevalence of lifestyle related health issues such as obesity, mental health issues, and stress level among working professionals due to lack of exercise and workout has increased the prevalence of heart diseases. Such factors are estimated to increase the market growth of digital therapeutics market in the future.

Access to FREE Sample Report Here! @ https://www.researchdive.com/download-sample/691

Key Players in the Digital Therapeutics Market

The companies involved in the digital therapeutics market are

  1. Noom
  2. Livongo Health
  3. Omada Health
  4. WellDoc
  5. Pear Therapeutics
  6. Proteus Digital Health
  7. Propeller Health
  8. Akili Interactive Labs
  9. Better Therapeutics
  10. Happify.
Labels:

Comments

Post a Comment

Popular posts from this blog

Collaborative Robot (Cobot) Market Insights Deep Analysis 2022-2030

  With the advancements in technology, robotics is becoming available at a price that suits the pockets of even smaller as well as bigger companies. All thanks to the development of low-cost components, which have paved way for the   upsurge of the collaborative robots or cobots  .Collaborative robots are intended to collaborate with humans at work sites, and hence making automation a trouble-free job for businesses of all sizes. By now, cobots have been seen as a game-changer for a wide variety of applications. W hy cobots over traditional robots? The new robotics technology is outdoing the weighty, daunting robots usually locked in the cages for security reasons. Now, it’s time to make use of cobots in those heavy industrial tasks! These robots are quite affordable, safe, and flexible to deploy. They are programmed to work in collaboration with humans and not under humans—unlike traditional robots. With these advanced-automated robots, you can forget the cages and make ...
Post a Comment
Read more

Intraoperative Neuromonitoring Market Revenue to Record Stellar Growth Rate

  According to  Intraoperative Neuromonitoring Market   Analysis by Research Dive, the global market forecast will be   $3,413.0 million   by the end of 2026 , at a   4.5% CAGR , growing from   $2,400.0 million in the end of 2018 . Intraoperative Neuromonitoring Market Drivers: Growing aged populace globally, along with increasing occurrence of chronic illnesses, are the major driving aspects for the intraoperative neuromonitoring market growth. Furthermore, intraoperative monitoring is an important process that assists in risk management throughout complex surgeries. This factor is projected to propel the market size in the coming years. Furthermore, rising trend of medical tourism along with growing investments for healthcare infrastructure in developing economies are projected to create significant revenue generating opportunities in the global market. Nevertheless, shortage of trained workforce for the control and maintenance of intraoperative neur...
Post a Comment
Read more

2-ethylhexyl Caprate Market to Incur Meteoric Growth During 2018-2026

Introduction: 2-Ethylhexyl Caprate Market 2-ethylhexyl caprate , also known as 2-ethylhexyl decanoate, is an organic chemical compound with the molecular formula C18H32O2. In the manufacturing of 2-ethylhexyl caprate, ethyl reacts with hexyl in the presence of caproic acid as a catalyst to form 2-ethylhexyl caproic acid, which on further treatment with esterification process forms a mixture of 2-ethylhexyl caprate crude. This mixture of 2-ethylhexyl caprate crude is distilled to obtain pure 2-ethylhexyl caprate. 2-ethylhexyl caprate finds several applications in chemical, pharmaceutical and textile industries as a reagent, catalyst and excipient. Along with this, 2-ethylhexyl caprate is used in the manufacturing of elastomers and coatings. On the basis of safety, 2-ethylhexyl caprate is the least harmful in the available caprate group and has low vapor pressure, which can reduce hazards while handling as compared to other caprates, such as ethylhexyl palmitate and oth...
Post a Comment
Read more